FDA’s Authority, Comstock Act In Spotlight Ahead Of Mifepristone SCOTUS Arguments

The Supreme Court will hear oral arguments Tuesday (March 26) in one of the most potentially consequential cases for health care this term, the FDA v. Alliance for Hippocratic Medicine case over prescription of the abortion pill mifepristone. Health stakeholders will be looking for indications of the justices’ stances on several issues, including whether a ruling against FDA could imperil the agency’s authority on other product approvals and whether the 1870s Comstock Act is relevant to the legal status...